Shu Zhang

ORCID: 0000-0003-0573-2019

Also affiliated with University of Hawaii System, Sichuan University, West China Hospital of Sichuan University, Cancer Center of Hawaii, University of Hawaii Cancer Center

MedicineNeuroscienceSocial SciencesEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Targeting mTORC2-dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET–activated and β-catenin–mutated hepatocellular carcinoma”.

Targeting mTORC2-dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET–activated and β-catenin–mutated hepatocellular carcinoma

Hepatology(2025)10.1097/hep.0000000000001637

N/A

0DataRank · unranked

2 citations

Yi Zhou, Shu Zhang, Christine Farrar, Xuemei Xie, Jian Li +18 more